PaulWesleyNobleMD

Interstitial Lung Diseases

Chairman, Department of Medicine, Cedars-Sinai Medical Center

Dr. Noble is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
8700 Beverly Blvd
Ste 2119
West Hollywood, CA 90048
Phone+1 310-423-1888

Fax+1 310-423-2665

University of ColoradoFellowship, Pulmonary Disease and Critical Care Medicine, 1988 - 1991
University of California (San Francisco)Chief Residency, Internal Medicine, 1987 - 1988
University of California (San Francisco)Residency, Internal Medicine, 1984 - 1987
New York University School of MedicineClass of 1984

PubMed

382 citations
Pulmonary fibrosis: patterns and perpetrators
Paul W. Noble, Christina E. Barkauskas, Dianhua Jiang
The Journal of Clinical Investigation. 2012-08-01
126 citations
Time for a change: is idiopathic pulmonary fibrosis still idiopathic and only fibrotic?
Paul J. Wolters, Timothy S. Blackwell, Oliver Eickelberg, James E. Loyd, Naftali Kaminski
The Lancet. Respiratory Medicine. 2018-02-01
12 citations
SOX9 switch links regeneration to fibrosis at the single-cell level in mammalian kidneys.
Shikhar Aggarwal, Zhanxiang Wang, David Rincon Fernandez Pacheco, Anna Rinaldi, Alex Rajewski
Science. 2024-02-23

Pulmonary Fibrosis Foundation Adds Cedars-Sinai to Care Center NetworkDecember 23rd, 2022
Cedars-Sinai Named to Pulmonary Fibrosis Foundation Care Center NetworkDecember 16th, 2022
Lassen Therapeutics Announces the Appointment of a Highly Experienced Biotech Executive to Its Board of Directors and the Expansion of Its Scientific and Clinical Advisory Board with Leading Experts in Pulmonary Fibrosis and Clinical DevelopmentOctober 7th, 2021
Join now to see all

Innate Immune Mechanisms In Non-Infectious Lung InflammationNational Institute Of Allergy And Infectious Diseases2008–2012
Matrix Regulation Of Pulmonary FibrosisNational Heart, Lung, And Blood Institute2011
Regulation Of Pulmonary Fibrosis By CXCR3National Heart, Lung, And Blood Institute2006–2011
Interdisciplinary Training Program In Lung DiseaseNational Heart, Lung, And Blood Institute2006–2011
Mechanisms Of Macrophage Activation In Lung InflammationNational Heart, Lung, And Blood Institute2006–2010
Matrix Regulation Of Fibroproliferative Lung DiseaseNational Heart, Lung, And Blood Institute2006–2010
Immune Mechanisms In Non-Infectious Lung InflammationNational Institute Of Allergy And Infectious Diseases2006
Survivin Regulation Of Pulmonary FibrosisNational Heart, Lung, And Blood Institute2006
Regulation Of Pulmonary Fibrosis By CXCR3National Heart, Lung, And Blood Institute2005–2006
Survivin Regulation Of Pulmonary FibrosisNational Heart, Lung, And Blood Institute2003–2005
Immune Mechanisms In Non-Infectious Lung InflammationNational Institute Of Allergy And Infectious Diseases2002–2005
Mechanisms Of Macrophage Activation In Lung InflammationNational Heart, Lung, And Blood Institute1997–2005
Regulation Of Macrophage Phenotypes In Lung RepairNational Heart, Lung, And Blood Institute1992–1996